Case Challenge

Management of a 69-Year-Old Patient With Deletion 5q Myelodysplastic Syndrome

Source: Treatment Challenges in Myelodysplastic Syndromes

Management of a 69-Year-Old Patient With Deletion 5q Myelodysplastic Syndrome


Faculty:

  • Alan F. List, MD

CME CREDIT INFORMATION

Release Date: 04/09/08

Expiration Date: 04/08/09


Physicians: maximum of 0.5 AMA PRA Category 1 Credit(s)™

Registered Nurses: 0.7 Nursing CE credit

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Summarize initial treatment options for patients with newly diagnosed low-risk myelodysplastic syndromes
  • Describe the appropriate use of erythropoiesis-stimulating agents in the treatment of patients with myelodysplastic syndromes
  • Discuss recent data from clinical studies of azacitidine and decitabine for myelodysplastic syndromes
  • Define the settings in which lenalidomide would be used to treat myelodysplastic syndromes

Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.